Silencing Mediator for Retinoid and Thyroid Hormone Receptors Interacts with Octamer Transcription Factor-1 and Acts as a Transcriptional Repressor*

Octamer transcription factor-1 (Oct-1) is a member of the POU (Pit-1, Oct-1,unc-86) family of transcription factors and is involved in the transcriptional regulation of a variety of gene expressions related to cell cycle regulation, development, and hormonal signals. It has been shown that Oct-1 acts not only as a transcriptional activator but also as a transcriptional repressor for certain genes. The mechanism of the repressive function of Oct-1 has not been well understood. Here we demonstrate by using the glutathione S-transferase pull-down assays and coimmunoprecipitation assays that the POU domain of Oct-1 directly interacts with a silencing mediator for retinoid and thyroid hormone receptors (SMRT). The interaction surfaces are located in the C-terminal region of SMRT, which are different from previously described silencing domains I and II or receptor interacting domains I and II. In transient transfection assays in COS1 cells, overexpression of SMRT attenuated the augmentation of Oct-1 transcriptional activity by OBF-1/OCA-B, activator for Oct-1. In pull-down assays, increasing amounts of SMRT could compete the binding of OCA-B to Oct-1 POU domain. The activity of Oct-1 could be determined by a regulated balance between SMRT and OCA-B. Furthermore, cotransfected unliganded thyroid hormone receptor enhanced the transactivation by Oct-1, and addition of 3,3′,5-tri-iodo-l-thyronine obliterated the stimulatory effects. Consequently, in the presence of cotransfected thyroid hormone receptor, the octamer response element acts as an element negatively regulated by 3,3′,5-tri-iodo-l-thyronine. The results suggest that the transcriptional activity of Oct-1 can be modulated by interaction through its POU domain by a silencing mediator SMRT resulting in the cross-talk between Oct-1 and nuclear receptors.

[1]  D. Huylebroeck,et al.  Oct-1 is involved in the transcriptional repression of the von willebrand factor gene promoter. , 1998, Blood.

[2]  K. Ichikawa,et al.  Functional Interaction between Oct-1 and Retinoid X Receptor* , 1999, The Journal of Biological Chemistry.

[3]  N. Segil,et al.  The Cyclin-dependent Kinase-activating Kinase (CAK) Assembly Factor, MAT1, Targets and Enhances CAK Activity on the POU Domains of Octamer Transcription Factors* , 1997, The Journal of Biological Chemistry.

[4]  S. Minucci,et al.  Aberrant Recruitment of the Nuclear Receptor Corepressor-Histone Deacetylase Complex by the Acute Myeloid Leukemia Fusion Partner ETO , 1998, Molecular and Cellular Biology.

[5]  S. Schreiber,et al.  Nuclear Receptor Repression Mediated by a Complex Containing SMRT, mSin3A, and Histone Deacetylase , 1997, Cell.

[6]  F. Coenjaerts,et al.  The Oct‐1 POU domain stimulates adenovirus DNA replication by a direct interaction between the viral precursor terminal protein‐DNA polymerase complex and the POU homeodomain. , 1994, The EMBO journal.

[7]  R. Roeder,et al.  Oct-1 and Oct-2 potentiate functional interactions of a transcription factor with the proximal sequence element of small nuclear RNA genes. , 1992, Molecular and cellular biology.

[8]  K. Ichikawa,et al.  Purification and characterization of thyroid hormone-responsive rat hepatic proteins. , 1991, Endocrinology.

[9]  W. Herr,et al.  The POU domain is a bipartite DNA-binding structure , 1988, Nature.

[10]  L. Poellinger,et al.  Functional interference between the ubiquitous and constitutive octamer transcription factor 1 (OTF-1) and the glucocorticoid receptor by direct protein-protein interaction involving the homeo subdomain of OTF-1 , 1992, Molecular and cellular biology.

[11]  M. Gstaiger,et al.  The B cell coactivator Bob1 shows DNA sequence‐dependent complex formation with Oct‐1/Oct‐2 factors, leading to differential promoter activation. , 1996, The EMBO journal.

[12]  R. Roeder,et al.  Coactivation by OCA-B: Definition of Critical Regions and Synergism with General Cofactors , 1998, Molecular and Cellular Biology.

[13]  R. Shiekhattar,et al.  A core SMRT corepressor complex containing HDAC3 and TBL1, a WD40-repeat protein linked to deafness. , 2000, Genes & Development.

[14]  C. Glass,et al.  ETO, a Target of t(8;21) in Acute Leukemia, Interacts with the N-CoR and mSin3 Corepressors , 1998, Molecular and Cellular Biology.

[15]  R. Roeder,et al.  Cloning, functional characterization, and mechanism of action of the B-cell-specific transcriptional coactivator OCA-B , 1995, Molecular and cellular biology.

[16]  S. Okret,et al.  Glucocorticoids Repress Transcription from a Negative Glucocorticoid Response Element Recognized by Two Homeodomain-containing Proteins, Pbx and Oct-1* , 1998, The Journal of Biological Chemistry.

[17]  T. Wirth,et al.  The POU domains of the Oct1 and Oct2 transcription factors mediate specific interaction with TBP. , 1994, Nucleic acids research.

[18]  P. Matthias,et al.  Coactivator OBF-1 Makes Selective Contacts with Both the POU-Specific Domain and the POU Homeodomain and Acts as a Molecular Clamp on DNA , 1998, Molecular and Cellular Biology.

[19]  T. Wirth,et al.  High mobility group protein 2 functionally interacts with the POU domains of octamer transcription factors. , 1995, The EMBO journal.

[20]  C. Glass,et al.  Signal-specific co-activator domain requirements for Pit-1 activation , 1998, Nature.

[21]  G. Ruvkun,et al.  The POU domain: a large conserved region in the mammalian pit-1, oct-1, oct-2, and Caenorhabditis elegans unc-86 gene products. , 1988, Genes & development.

[22]  C. Glass,et al.  A complex containing N-CoR, mSln3 and histone deacetylase mediates transcriptional repression , 1997, nature.

[23]  G. Bell,et al.  Characterization of a third human thyroid hormone receptor coexpressed with other thyroid hormone receptors in several tissues. , 1988, Molecular endocrinology.

[24]  N. Heintz,et al.  Purification and characterization of OTF-1, a transcription factor regulating cell cycle expression of a human histone H2b gene , 1987, Cell.

[25]  S. Inoue,et al.  Role of the histone deacetylase complex in acute promyelocytic leukaemia , 1998, Nature.

[26]  A. Dejean,et al.  SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor α (RARα) and PLZF-RARα oncoproteins associated with acute promyelocytic leukemia , 1997 .

[27]  M. Montminy,et al.  Pbx-Hox Heterodimers Recruit Coactivator-Corepressor Complexes in an Isoform-Specific Manner , 1999, Molecular and Cellular Biology.

[28]  G. Hager,et al.  The Glucocorticoid Receptor Is Tethered to DNA-bound Oct-1 at the Mouse Gonadotropin-releasing Hormone Distal Negative Glucocorticoid Response Element* , 1999, The Journal of Biological Chemistry.

[29]  T. Hoshino,et al.  ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[30]  W. Herr,et al.  The ubiquitous octamer-binding protein Oct-1 contains a POU domain with a homeo box subdomain. , 1988, Genes & development.

[31]  Rhian F. Walther,et al.  Selective Binding of Steroid Hormone Receptors to Octamer Transcription Factors Determines Transcriptional Synergism at the Mouse Mammary Tumor Virus Promoter* , 1999, The Journal of Biological Chemistry.

[32]  H. Nakshatri,et al.  Interaction of Oct-1 with TFIIB , 1995, The Journal of Biological Chemistry.

[33]  J. Cheong,et al.  Silencing Mediator of Retinoic Acid and Thyroid Hormone Receptors, as a Novel Transcriptional Corepressor Molecule of Activating Protein-1, Nuclear Factor-κB, and Serum Response Factor* , 2000, The Journal of Biological Chemistry.

[34]  E. Bertolino,et al.  Using altered specificity Oct‐1 and Oct‐2 mutants to analyze the regulation of immunoglobulin gene transcription , 1997, The EMBO journal.

[35]  J. Newell,et al.  OBF-1, a novel B cell-specific coactivator that stimulates immunoglobulin promoter activity through association with octamer-binding proteins , 1995, Cell.

[36]  Thorsten Heinzel,et al.  Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor , 1995, Nature.